Skip to main content
. Author manuscript; available in PMC: 2014 Apr 30.
Published in final edited form as: Cochrane Database Syst Rev. 2010 Sep 8;(9):CD007575. doi: 10.1002/14651858.CD007575.pub2
Methods Within a series of studies; a double-blind comparative experiment, a controlled double blind study
Participants 100 ward (not explained) and private patients.
Interventions Bendectin (10 mg each of Bentyl, Decapryn and Pyridoxine), 2 tablets nightly, an additional tablet in the morning as required
Placebo (not described).
Outcomes Relief from nausea and vomiting: complete, partial or no relief No description of how or when outcomes were measured.
Notes
Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear No description about randomisation.
Allocation concealment? Unclear No description about allocation concealment; tablets were in envelopes with an identification number
Blinding?
Change in grade of nausea or vomiting at second visit compared to first
Yes Neither the physician nor the patient was aware of the identity of the tablet administered
Incomplete outcome data addressed?
Change in grade of nausea or vomiting at
second visit compared to first
Yes 1 patient in treatment group received medication for 1 day, otherwise all patients’ outcomes reported in results
Free of selective reporting? Yes Outcomes reported.
Free of other bias? Unclear 2 patients were included in both the treatment and control groups as they received medication on 2 separate occasions during the study
Not stated how or when outcomes were recorded.